Determining The Impacts Of COVID-19 Restrictions On People Who Use Drugs
Funder
National Health and Medical Research Council
Funding Amount
$429,228.00
Summary
COVID-19 has resulted in unparalleled government interventions to close borders and restrict social interactions which have major implications for illicit drug supply, procurement and use practices, as well as responses. People who use drugs will be profoundly impacted by COVID-19 and so our study will leverage existing data collections to compare drug use practices and consequences before, during and after the COVID-19 interventions to determine COVID-19 impacts on people who use drugs.
Repurposing And Re-optimising Drugs That Disrupt Glycoprotein Folding To Treat COVID-19
Funder
National Health and Medical Research Council
Funding Amount
$1,199,874.00
Summary
As of June 2020, COVID-19 has infected over 7.3 million people and killed over 413,000 in the six months since it emerged. It has pushed many healthcare systems and economies to breaking point. We recently discovered that a known drug is effective at stopping the virus under laboratory conditions. This research will determine exactly how the drug works, evaluate it's potential in pre-clinical models, and re-optimise the drug's antiviral properties to ensure that we can prevent future pandemics.
Better Statistical Methods To Discover Host Genetic Factors In Symptom Response To SARS-CoV-2 Infection
Funder
National Health and Medical Research Council
Funding Amount
$290,137.00
Summary
The COVID-19 pandemic has infected >5 million people worldwide. While the majority of infected individuals recover within a few weeks of infection, others develop severe forms, that in some cases prove fatal. To date, the causes of differences in symptom response are unknown. In this proposal, we seek to discover genetic factors that can contribute to explaining these differences. Our findings have the potential to inform the design and analysis of clinical trials for vaccines and treatments.
The Impact Of The COVID-19 Pandemic On Sexual And Reproductive Health Services And Outcomes In The Pacific Islands And Territories
Funder
National Health and Medical Research Council
Funding Amount
$110,703.00
Summary
Delivery of sexual and reproductive health (SRH) services was curtailed in the Pacific Island countries and territories, as already limited resources were redistributed towards meeting priorities dictated by the COVID-19 pandemic. This project will investigate, analyse and quantify the impact on SRH outcomes. It will explore the experiences of SRH policy changes during the pandemic and aim to collaboratively develop a management plan for SRH programs should another pandemic occur in the future.